# To Study Efficacy of Albumin in Cirrhosis With Spontaneous Bacterial Peritonitis at Low Risk for AKI Development

> **NCT04437810** · NA · UNKNOWN · sponsor: **Institute of Liver and Biliary Sciences, India** · enrollment: 100 (estimated)

## Conditions studied

- Liver Cirrhosis
- Acute Kidney Injury

## Interventions

- **BIOLOGICAL:** Albumin
- **OTHER:** Standard Medical Treatment

## Key facts

- **NCT ID:** NCT04437810
- **Lead sponsor:** Institute of Liver and Biliary Sciences, India
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-08
- **Primary completion:** 2022-04-30
- **Final completion:** 2022-04-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2022-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04437810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04437810, "To Study Efficacy of Albumin in Cirrhosis With Spontaneous Bacterial Peritonitis at Low Risk for AKI Development". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04437810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*